Minority / Underserved – Diversity, Equity & Inclusion

While Cures Within Reach is disease-agnostic and geography-agnostic, some of our funding partners have strategic interests in specific population groups.  Therefore, in addition to our disease-specific and geographic repurposing communities, we have a Minority and Underserved Repurposing Community to support Diversity, Equity & Inclusion (DEI) efforts that utilizes the speed and cost-effectiveness of testing already approved therapies in new indications to improve the quality and length of life of minority and underserved patients as well as to support minority and underserved researchers.


We support Diversity, Equity & Inclusion efforts by finding and funding clinical repurposing projects to improve overall health equity and clinical trial diversity:


  • Led by Minority and Underserved Researchers in any disease area (underserved according to a 2020 NIH report on racial disparities in NIH funding)
  • To positively impact Health Disparities within communities of color (including engagement of community-based health and social services organizations) 
  • To impact patients living in low and low-middle income countries (LMICs, as defined by the World Bank)

Open Funding Opportunities in Diversity, Equity & Inclusion:

More information on our Funding Opportunities / RFPs page.

As we develop and grow this Community, Cures Within Reach thanks our early funding partners:

Searle Funds at the Chicago Community Trust logo

for its support of our first project in Health Disparities: “Can Vitamin D reduce the burden of COVID-19?” focusing on Black and Hispanic Chicagoans and our Health Disparities initiative for Chicago,


Industry leader Takeda Pharmaceuticals supports repurposing research

for its support of our initiative to impact Minority and Underserved patients and researchers.


Our DEI trials include:

Dr. Hamaluba researching snakebites in Kenya

Dr. Adewole researching tuberculosis in Nigeria

Dr. Nguyen researching a rare pediatric disease in Vietnam


Events and Media

Diversity of Clinical Trial Researchers and Patients: A Repurposing Opportunity?
November 2021
A dialogue on the dual opportunities of clinical trial diversity to impact health disparities and/or improve minority leadership in scientific research.

Real World Data Through a Patient’s Lens
October 2021
A conversation on Real World Data (RWD) and case reports from clinicians and researchers.

Learn about our Health Disparities project in COVID-19 focused on Black and Latinx communities by watching Dr. Meltzer of University of Chicago interviewed on ABC7 Chicago and Fox Chicago and reading more in the Chicago Tribune.

Cure Accelerator Live! for Chicago 2020
September 2020
Four finalists from Chicago-based institutions competing for up to $50,000 to fund their repurposing clinical trials, including a minority-led project.  Watch Dr. Lindsey pitch his project.

CureAccelerator Live! for Rare Diseases 2020
June 2020
Five finalists from the US competing for up to $50,000 to fund their repurposing clinical trials impacting rare disease patients – including a minority led project.  Read more about Dr. Phillips’ project and watch him pitch it.

CureAccelerator Live! for the Developing World 2019
May 2019
Boston, MA
Five finalists from the US and India competing for up to $50,000 to fund their repurposing clinical trials impacting patients in the Developing World.

Completed DEI – Minority / Underserved Research(er) Projects

(in the past 3 years)